Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term

HCA Healthcare, the largest non-governmental operator of acute care hospitals in the U.S., is identified as a compelling growth prospect. While holding a Zacks #3 (Hold) rank, the company features an "A" Growth Style Score and VGM Score, underpinned by a projected 18.9% year-over-year earnings growth for the current fiscal year. Analysts have also raised fiscal 2025 earnings estimates, with the Zacks Consensus Estimate increasing to $26.11 per share, reinforcing HCA's appeal to growth investors given its consistent 7% average earnings surprise.

Analysis

HCA Healthcare (HCA), the largest non-governmental U.S. hospital operator, presents a compelling growth profile despite a neutral Zacks #3 (Hold) rank. The company's fundamental strength is underscored by its top-tier 'A' ratings for both its Growth Style Score and its combined VGM (Value, Growth, Momentum) Score. This is substantiated by a forecast for significant 18.9% year-over-year earnings growth in the current fiscal year. Analyst sentiment is firmly positive, with ten upward earnings estimate revisions for fiscal 2025 in the past 60 days, which has driven the Zacks Consensus Estimate up by $0.81 to $26.11 per share. This forward-looking optimism is supported by HCA's historical performance, which includes a consistent average earnings surprise of +7%, demonstrating a pattern of exceeding market expectations.

Key Decisions for Investors

• Given the strong 'A' rating for Growth and a projected 18.9% earnings increase, growth-focused investors should consider HCA as a candidate for their portfolio, aligning with the article's suggestion to place it on a short list.
• Investors should investigate the discrepancy between the neutral Zacks #3 (Hold) rank and the strong underlying growth metrics to understand potential risks or valuation concerns not fully detailed in this growth-focused summary.
• It is crucial to monitor the trend of analyst earnings revisions and future earnings reports, as continued positive momentum in estimates is a key pillar supporting the current investment thesis.